Figure 1From: Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL) Management flow chart according to the modified stage; CR, complete remission; PR, partial remission; PD, progressive disease; NE, not evaluable; RT, radiotherapy; ASCT, autologous stem cell transplantation. Back to article page